Banzai International (BNZI) said Tuesday its lenders and service providers agreed to write off up to $5.6 million of outstanding liabilities and restructure $19.2 million of existing debt obligations.
Shares almost doubled as intraday trading volume soared to over 51.6 million from a daily average of about 1.05 million.
Seelos Therapeutics (SEEL) said Tuesday its SLS-002 was selected for inclusion in the US Department of Defense's Military and Veterans Adaptive Platform Clinical Trial to evaluate its potential for treatment of post-traumatic stress disorder.
Shares surged 81% as intraday trading volume climbed to more than 308 million from a daily average of about 2.04 million.
Wave Life Sciences (WVE) shares soared 50% after the company reported Tuesday "positive" interim data from a phase 2 trial of WVE-N531 to treat boys with Duchenne muscular dystrophy who are amenable to exon 53 skipping.
More than 11.7 million shares were traded intraday, compared with a daily average of about 897,000.
Price: 8.14, Change: +3.94, Percent Change: +93.69
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。